Stellaromics Inc.

Stellaromics Inc.

Biotechnology Research

Boston, Massachusetts 5,920 followers

Achieve your next breakthrough using the world’s most powerful 3D in situ multi-omic analysis technology

About us

Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue. At the forefront of their innovation is STARmap (Spatially-resolved Transcript Amplicon Readout mapping), their flagship product. STARmap empowers researchers to uncover gene expression patterns within intact tissue, facilitating the pinpointing of treatment targets and bolstering biomedical investigations. Stellaromics is currently in the advanced stages of developing its Pyxa™ suite of products, meticulously crafted to empower researchers and clinicians in the creation of intricate cellular maps, thereby amplifying our comprehension of various diseases. For comprehensive details, we invite you to explore our website at stellaromics.com. Join us in shaping the future of biomedical research.

Website
www.stellaromics.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Boston, Massachusetts
Type
Privately Held
Founded
2022
Specialties
Spatial transcriptomics, Genomics, Multi-omics, Functional genomics, RNA therapeutics, and Small RNA detection

Locations

  • Primary

    321 Harrison Ave 6th Floor

    Boston, Massachusetts 02118, US

    Get directions

Employees at Stellaromics Inc.

Updates

Similar pages

Browse jobs

Funding

Stellaromics Inc. 1 total round

Last Round

Series A

US$ 25.0M

See more info on crunchbase